MedPath

Functional MRI Study of Cortical Modifications to Light Stimulation in Patients With Photophobia

Not Applicable
Conditions
Dry Eye Syndrome
Photophobia
Interventions
Radiation: fMRI
Registration Number
NCT03464357
Lead Sponsor
University Hospital, Toulouse
Brief Summary

Photophobia is a common and disabling symptom in patient with dry eye syndrome. The aim of this study is tried to better understand this complain analyzing brain activation during a luminous stimulation to highlight modification of cortical activation.

Detailed Description

Dry eye syndrome is a frequent and underestimated disease whose incidence tends to increase because of the population ageing and behaviors modification (time spent using screens increased, wearing of contact lenses...). Photophobia deteriorates the quality of life in patients with dry eye syndrome decreasing outdoor activities. This symptom is not understood and does not seem to be linked with dry eye syndrome severity. The study will compare cortical activation after luminous stimulation of 16 patients eyes (8 patients with dry eye syndrome and photophobia vs 8 asymptomatic patients) using functional MRI (fMRI).

The primary study endpoint was the extent of magnetic signals in visual cortex after luminous stimulation. Secondary endpoints were the spatial activation extent in the 3 areas of the visual cortex (Brodmann areas 17,18,19).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
16
Inclusion Criteria
  • Symptomatic subjects : presence of bilateral photophobia with an impact on daily activities (driving, outdoor activities, screens use, socio-professional activities...) in a context of patent dry eye syndrome
  • Asymptomatic subjects : no dry eye syndrome and no photophobia
  • Patients able to understand medical information and sign consent.
Exclusion Criteria
  • Ophthalmological pathologies of cornea, iris, optic nerve or retina
  • MRI contraindications (metallic prosthesis, pacemaker, claustrophobia)
  • Neurological pathology which may affect MRI results
  • Subjects under legal protection

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Symptomatic patients with dry eyefMRI8 symptomatic patients with dry eye (mild to severe) assessed using a validated questionnaire (OSDI score, Appendix 1) associated with a disabling photophobia (need to wear sunglasses permanently outside, restriction of the outputs in case of significant brightness, restriction of the use of the screens because of the visual embarrassment ...). The fMRI will be carried out following the inclusion visit after all the necessary checks
Asymptomatic patientfMRI8 asymptomatic patients presenting neither photophobia (even minimal) or dry eye. The fMRI will be carried out following the inclusion visit after all the necessary checks
Primary Outcome Measures
NameTimeMethod
The spatial extent of activation of the visual cortexOne day

Measurement of voxel activation is validated and standardized (SPM8 software (Wellcome Department of Cognitive Neurology, London, UK) . In order to be able to determine the anatomical location of the voxels, a registration of the images on the standard image MNI152 (Montreal National Institute) provided by the Montreal Neurological Institute for which the spatial location of all the areas is known will be realized. It will thus be obtained, the number of activated voxels per visual area (Brodmann 17, 18, 19) for each hemisphere (contralateral and ipsilateral) of a subject with or without complaint.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University Hospital Toulouse

🇫🇷

Toulouse, France

© Copyright 2025. All Rights Reserved by MedPath